Bilian Yu
- Aging top 1%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 12
- Physiology top 5%
-
- Cancer, Lipids, and Metabolism 6
-
- Lipid metabolism and disorders 6
- Cardiomyopathy and Myosin Studies 5
-
- Lipoproteins and Cardiovascular Health 13
- Cholesterol and Lipid Metabolism 9
-
- Peroxisome Proliferator-Activated Receptors 10
-
- Adipokines, Inflammation, and Metabolic Diseases 8
Bilian Yu
56 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Aging 181
- Endocrinology, Diabetes and Metabolism 274
- Physiology 384
- Cancer Research 158
- Cardiology and Cardiovascular Medicine 228
Countries citing papers authored by Bilian Yu
This map shows the geographic impact of Bilian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilian Yu more than expected).
Fields of papers citing papers by Bilian Yu
This network shows the impact of papers produced by Bilian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilian Yu. The network helps show where Bilian Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bilian Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 10 | |
| 11 | 2020 | 42 | |
| 12 | 2017 | 16 | |
| 13 | 2016 | 1 | |
| 14 | 2014 | 61 | |
| 15 | 2013 | 4 | |
| 16 | 2010 | 2 | |
| 17 | 2009 | 8 | |
| 18 | 2007 | 10 | |
| 19 | 1993 | 100 | |
| 20 | 1988 | 186 |
About Bilian Yu
Bilian Yu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 62 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (13 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers), Peroxisome Proliferator-Activated Receptors (10 papers), Cholesterol and Lipid Metabolism (9 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers), Lipid metabolism and disorders (6 papers), Cancer, Lipids, and Metabolism (6 papers) and Cardiomyopathy and Myosin Studies (5 papers). The work is most often cited by research in Aging (181 citations), Endocrinology, Diabetes and Metabolism (274 citations) and Physiology (384 citations). Bilian Yu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shui‐Ping Zhao, Edward J. Masoro, C. A. Gleiser, Keisuke Iwasaki, Daoquan Peng, Chenlu Wu, Qin Luo, C. Alex McMahan, Xiaoyu Tang and C. Alex McMahan. Their work appears in journals such as Lipids in Health and Disease, Atherosclerosis, Scientific Reports, The Journals of Gerontology Series A and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.